Global Medical REIT Inc.
GMRE, GMRE-PAOther · Accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $526,000 | $370,000 | $115,000 | $116,000 | $132,000 | $212,000 |
| Operating income | — | — | — | — | — | — |
| Net income | −$6.9M | $6.7M | $21.7M | $20.0M | $18.3M | −$2.5M |
| Total assets | $1.24B | $1.26B | $1.27B | $1.39B | $1.26B | $1.10B |
| Total liabilities | $712.4M | $700.6M | $661.9M | $744.2M | $625.9M | $643.1M |
| Equity | $509.8M | $534.1M | $583.6M | $633.0M | $622.8M | $444.8M |
| EPS (diluted) | $-0.91 | $0.01 | $0.23 | $0.20 | $0.19 | $-0.17 |
| Shares out. | 66.9M | 65.6M | 65.5M | 65.4M | 52.2M | 44.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- −1308.6%
- Return on equity
- −1.4%
- Return on assets
- −0.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 57.3%
- Debt / equity
- 1.40×
- Book value / share
- $7.62
- Revenue growth (YoY)
- 42.2%
- Net income growth (YoY)
- −202.9%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −6.5%clean
- Piotroski F-Score
- 3/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Reported a net loss
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Dec 1, 2014
- NT 10-Qmissed a reporting deadline ↗Jul 15, 2014
- NT 10-Qmissed a reporting deadline ↗Apr 15, 2014
- NT 10-Qmissed a reporting deadline ↗Apr 16, 2013
- NT 10-Qmissed a reporting deadline ↗Jan 15, 2013
- NT 10-Qmissed a reporting deadline ↗Jul 16, 2012
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Cypher MatthewDirector | May 14, 2026 | Buy | 1,420 | $35.12 |
| Wittman LoriDirector | May 12, 2026 | Buy | 2,940 | $33.85 |
| Marston RonaldDirector | May 12, 2026 | Buy | 189 | $34.05 |
| Barber Jamie AllenOfficer — General Counsel and Secretary | May 12, 2026 | Buy | 1,481 | $33.50 |
| Kiernan Robert JOfficer — CFO and Treasurer | May 11, 2026 | Buy | 3,000 | $33.49 |
| Holley DanicaOfficer — COO | May 12, 2026 | Buy | 1,490 | $33.99 |
| Decker Mark Okey JrOfficer — CEO and President | May 12, 2026 | Buy | 1,000 | $33.74 |
| Crowley PaulaDirector | May 11, 2026 | Buy | 1,000 | $34.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Director / officer change · Shareholder vote · Regulation FD disclosureMay 20, 2026
- Entered a material agreement · Unregistered equity saleMay 8, 2026
- Entered a material agreement · Results of operations · Regulation FD disclosure · Other material eventMay 6, 2026
- Entered a material agreement · Amended charter or bylaws · Other material eventMar 13, 2026
- Entered a material agreement · New financial obligationMar 3, 2026
- Results of operations · Amended charter or bylaws · Regulation FD disclosure · Other material eventFeb 25, 2026
- Director / officer changeJan 26, 2026
- Director / officer changeDec 4, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4OWNERSHIP DOCUMENTMay 21, 2026
- 4OWNERSHIP DOCUMENTMay 21, 2026
- 4OWNERSHIP DOCUMENTMay 21, 2026
- 4OWNERSHIP DOCUMENTMay 21, 2026
- 3OWNERSHIP DOCUMENTMay 20, 2026
- 8-KFORM 8-KMay 20, 2026
- 4OWNERSHIP DOCUMENTMay 15, 2026
- 4OWNERSHIP DOCUMENTMay 13, 2026
- 4OWNERSHIP DOCUMENTMay 13, 2026
- 4OWNERSHIP DOCUMENTMay 13, 2026
- 4OWNERSHIP DOCUMENTMay 12, 2026
- 4OWNERSHIP DOCUMENTMay 12, 2026
- 4OWNERSHIP DOCUMENTMay 12, 2026
- 4OWNERSHIP DOCUMENTMay 11, 2026
- 4OWNERSHIP DOCUMENTMay 11, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.